Business Context and Reporting Period
This Form 6-K filing by GlaxoSmithKline plc (GSK) covers the month of March 2022. The document serves as a notice regarding the publication of the Annual General Meeting (AGM) 2022 details.
Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report is administrative in nature and does not contain financial statements or performance data.
Material Changes
No material financial changes versus the prior comparable period are reported in this filing.
Guidance, Outlook, and Corporate Events
- AGM Announcement: GSK published the Notice of Annual General Meeting 2022 on its website.
- Meeting Details: The AGM is scheduled for Wednesday, May 4, 2022, at 2:30 pm.
- Location: The meeting will be held at the Sofitel London Heathrow, Terminal 5, London Heathrow Airport, TW6 2GD.
- Participation: The meeting will be broadcast live for electronic shareholder participation. Full details are available in the AGM Notice and Guide.
- Regulatory Compliance: The notice will be submitted to the UK Listing Authority and made available for inspection via the UK Financial Conduct Authority's National Storage Mechanism.
Key Facts for Investor Verification
- Verify the date and time of the 2022 AGM (May 4, 2022, 2:30 pm).
- Confirm the physical location and electronic access procedures for the AGM.
- Review the full AGM Notice and Guide on the GSK investor website for specific agenda items and voting instructions.
- Note that this filing contains no financial performance data; refer to the most recent Form 20-F or quarterly reports for financial metrics.